| 書目名稱 | Druggable Lipid Signaling Pathways | | 編輯 | Yasuyuki Kihara | | 視頻video | http://file.papertrans.cn/284/283174/283174.mp4 | | 概述 | Revisits historical achievements of lipid research and updates the latest understanding of lipid functions.Inspires new perspectives on discovering drugs in lipid signaling pathways.Written by the nex | | 叢書名稱 | Advances in Experimental Medicine and Biology | | 圖書封面 |  | | 描述 | .Lipids are responsible not just for constituting cellular membrane but also for storing energy, transducing signaling, and modifying proteins. Bioactive lipids, or lipid mediators, transduce signaling as intracellular messenger like phosphoinoitides, and also regulate cell-cell communication through G protein-coupled receptors (GPCRs) that are potentially valuable drug targets in many diseases. Until now, about 40 GPCRs within ~300 rhodopsin-like (class A) GPCRs, are identified as lipid GPCRs. Advances of lipid research have enabled to develop novel small molecules targeting lipid GPCRs for several diseases. Most notably, fingolimod (FTY720), a sphingosine 1-phosphate (S1P) receptor modulator, became the first FDA-approved medicine as an orally bioavailable drug for treating relapsing forms of multiple sclerosis (MS). In addition to fingolimod, other drugs targeting lipid GPCRs had been developed such as latanoprost (prostaglandin F2a analogue, used for ocular hypertension and glaucoma), epoprostenol and treprostinil (prostaglandin I2 analogue, used for pulmonary arterial hypertension), montelukast and pranlukast (cysteinyl leukotriene receptor antagonist, used for asthma and alle | | 出版日期 | Book 2020 | | 關鍵詞 | lipids; GPCR; drug discovery; disease; translational research | | 版次 | 1 | | doi | https://doi.org/10.1007/978-3-030-50621-6 | | isbn_softcover | 978-3-030-50623-0 | | isbn_ebook | 978-3-030-50621-6Series ISSN 0065-2598 Series E-ISSN 2214-8019 | | issn_series | 0065-2598 | | copyright | Springer Nature Switzerland AG 2020 |
The information of publication is updating
|
|
|Archiver|手機版|小黑屋|
派博傳思國際
( 京公網(wǎng)安備110108008328)
GMT+8, 2025-10-11 22:50
發(fā)表于 2025-3-21 18:52:45
